Postoperative maintenance therapy for inflammatory bowel disease

Current Opinion in Gastroenterology

Volumn 22, Issue 4, 2006, Pages 377-381

  Cottone, Mario ^a   Orlando, Ambrogio ^a   Modesto, Irene ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Clinical relapse; Crohn's disease; Endoscopic and surgical recurrence; Postoperative maintenance therapy; Smoking; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; ORNIDAZOLE; PLACEBO; PROBIOTIC AGENT;

CROHN DISEASE; DRUG EFFICACY; ENTERIC FEEDING; ENTERITIS; HUMAN; ILEITIS; MAINTENANCE THERAPY; MUCOSAL IMMUNITY; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PROGNOSIS; RELAPSE; REVIEW; RISK ASSESSMENT; SMOKING; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE ACTIVATION; UNSPECIFIED SIDE EFFECT;

ANTI-BACTERIAL AGENTS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; ENTERAL NUTRITION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; POSTOPERATIVE CARE; PROBIOTICS; TREATMENT OUTCOME;

EID: 33746220253     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mog.0000231811.95525.7c     Document Type: Review

References (31)

1. Carter MJ, Lobo AJ, Travis S. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 (Suppl V):V1-V16.
2. Cammà C, Giunta M, Rosselli M, Cottone M. Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 1997; 113:1465-1473.
3. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol 2005; 11:3971-3979. This Medline-based review takes into account factors affecting postoperative recurrence of Crohn's disease. The author identifies smoking, 5-ASA and long duration of disease as risk factors.
4. Markowitz J, Markowitz JE, Bousvaros A, et al. Workshop report: prevention of postoperative recurrence in Crohn's disease. J Pediatr Gastroenterol Nutr 2005; 41:145-151.
5. Keh C, Shatari T, Yamamoto T, et al. Jejunal Crohn's disease is associated with a higher postopertaive recurrence rate than ileocaecal Crohn's disease. Colorectal Dis 2005; 7:366-368.
6. Alvarez-lobos M, Arostegui JI, Sans M, et al. Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence. Ann Surg 2005; 242:693-700.
7. Cottone M, Orlando A, Viscido A, et al. Review article: prevention of post-surgical relapse and recurrence in Crohn's disease. Aliment Pharmacol Ther 2003; 17 (Suppl 2):38-42.
8. Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992; 33:779-782.
9. Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group. Gastroenterology 1998; 114:1143-1150.
10. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994; 106:643-648.
11. Sutherland LR, Ramcharan S, Bryant H, et al. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990; 98 (5 Pt 1):1123-1128.
12. Breuer-Katschinski BD, Hollander N, Goebell H. Effect of cigarette smoking on the course of Crohn's disease. Eur J Gastroenterol Hepatol 1996; 8:225-228.
13. Johnson GJ, Cosnes J, Mansfield JC. Review article: smoking cessation as primary therapy to modify the course of Crohn's disease. Aliment Pharmacol Ther 2005; 21:921-931.
14. Kane SV, Flicker M, Katz-Nelson F. Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission. J Clin Gastroenterol 2005; 39:32-35.
15. Avidan B, Sakhnini E, Lahat A, et al. Risk factors regarding the need for a second operation in patients with Crohn's disease. Digestion 2005; 72:248-253.
16. Penner RM, Madsen KL, Fedorak RN. Postoperative Crohn's disease. Inflamm Bowel Dis 2005; 11:765-777.
17. Cottone M, Camma C. Mesalamine and relapse prevention in Crohn's disease. Gastroenterology 2000; 119:597.
18. Froehlich F, Juillerat P, Felley C, et al. Treatment of postoperative Crohn's disease. Digestion 2005; 71:49-53.
19. Rutgeerts P, Hiele M, Geboes K, et al. Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 1995; 108:1616-1621.
20. Rutgeerts P, Van Assche G, Vermeire S, et al. Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2005; 128:856-861. This was the second randomized controlled trial on the role of antibiotics in preventing clinical relapse and endoscopic recurrence. The study showed that ornidazole is effective in preventing clincial relapse and endoscopic recurrence on intention to treat analysis.
21. Prantera C, Scribano ML, Falasco G, et al. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomized controlled trial with Lactobacillus GG. Gut 2002; 51:405-409.
22. Marteau P, Lemann M, Seksik P, et al. Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double-blind, placebo-controlled GETAID trial. Gut 2005; Dec 23 [Epub ahead of print]. This was the second trial on the role of probiotics in preventing endoscopic recurrence. The study confirmed the ineffectiveness of LA1 in maintenance treatment after surgery in Crohn's disease.
23. Gionchetti P, Rizzello F, Helwig U, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double blind, placebo controlled trial. Gastroenterology 2003; 124:1202-1209.
24. Gosselink MP, Schouten WR, van Lieshout LM, et al. Delay of the first onset of pouchitis by oral intake of the probiotics strain Lactobacillus rhamnosus GG. Dis Colon Rectum 2004; 47:876-884.
25. Gionchetti P, Rizzello F, Poggioli G, et al. Probiotic therapy to prevent pouchitis onset. Dis Colon Rectum 2005; 48:1493.
26. Lammers KM, Vergopoulos A, Babel N, et al. Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1 beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis 2005; 11:447-454.
27. Hanauer SB, Korelitz BI, Rutgeerts P, et al. Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial. Gastroenterology 2004; 127:723-729.
28. Ardizzone S, Maconi G, Sampietro GM, et al. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2004; 127:730-740.
29. Bitton A. Preventing postoperative recurrence in Crohn's disease with 6-mercaptopurine and azathioprine: approaching the cutting edge. Inflamm Bowel Dis 2005; 11:513-514.
30. Hayee BH, Harris AW. 6-Mercaptopurine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease. Gastroenterology 2005; 128:249.
31. Esaki M, Matsumoto T, Hizawa K, et al. Preventive effect of nutritional therapy against postoperative recurrence of Crohn disease, with reference to findings determined by intra-operative enteroscopy. Scand J Gastroenterol 2005; 40:1431-1437. This was the first open study which evaluated the role of enteral nutrition as possible treatment in prevention of clinical relapse after surgery.